Gen-Probe Shares Close Down on WSJ Report | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Gen-Probe fell more than 2 percent in Tuesday trade after a report in The Wall Street Journal said that Novartis was no longer "actively pursuing" a deal to acquire the San Diego-based molecular diagnostics firm.

Novartis was believed to be the sole remaining bidder for Gen-Probe after Life Technologies and Thermo Fisher Scientific reportedly backed out of the bidding process.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: tool to discover copy number variants, single-nucleus RNA sequencing study of myoblasts, and more.

A study of Tasmanian devil genomes suggests they are evolving resistance to devil facial tumor disease.

Theranos has withdrawn its request for emergency clearance of a Zika virus blood test, according to the Wall Street Journal.

An assistant professor who was fired from Mount Sinai School of Medicine has allegedly shot the school's dean, the New York Times reports.